Variant report
Variant | nsv548591 |
---|---|
Chromosome Location | chr1:191623693-191642616 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:191621018..191625151-chr1:191627413..191631107,4 | K562 | blood: | |
2 | chr1:191618527..191620299-chr1:191625178..191627507,2 | K562 | blood: | |
3 | chr1:191621018..191625151-chr1:191627413..191631107,4 | K562 | blood: | |
4 | chr1:191616602..191619321-chr1:191633804..191636058,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11804493 | chr1:191630028-191630029 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs540947441 | chr1:191630038-191630039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187282858 | chr1:191630058-191630059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs71639139 | chr1:191630102-191630103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545490306 | chr1:191630122-191630123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562245165 | chr1:191630138-191630139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs191844531 | chr1:191630198-191630199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs368397233 | chr1:191630245-191630246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs150672811 | chr1:191630257-191630258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs370307430 | chr1:191630258-191630259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs1336866 | chr1:191630277-191630278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs527569711 | chr1:191630289-191630290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs138848401 | chr1:191630342-191630343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs77731770 | chr1:191630345-191630346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533210796 | chr1:191630373-191630374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs371301202 | chr1:191630396-191630397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs552658321 | chr1:191630426-191630427 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569385988 | chr1:191630443-191630444 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10590530 | chr1:191630463-191630464 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538206713 | chr1:191630482-191630483 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs554642721 | chr1:191630516-191630517 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs118037702 | chr1:191630536-191630537 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs16833655 | chr1:191630540-191630541 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs182232119 | chr1:191630541-191630542 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs114506831 | chr1:191630579-191630580 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs574810880 | chr1:191630582-191630583 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs376795377 | chr1:191630585-191630586 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186466059 | chr1:191630618-191630619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs55897399 | chr1:191630637-191630638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7517393 | chr1:191630653-191630654 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs146340805 | chr1:191630660-191630661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs76827713 | chr1:191630685-191630686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs548483035 | chr1:191630688-191630689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs541937353 | chr1:191630763-191630764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs12025778 | chr1:191630788-191630789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs557530568 | chr1:191630799-191630800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs115054431 | chr1:191630864-191630865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540964714 | chr1:191630902-191630903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs564377893 | chr1:191630904-191630905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs533122717 | chr1:191630923-191630924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs550018568 | chr1:191630949-191630950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs10920987 | chr1:191631003-191631004 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs190287814 | chr1:191631042-191631043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs548702468 | chr1:191631107-191631108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs7528072 | chr1:191631131-191631132 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs66478619 | chr1:191631139-191631140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs71742038 | chr1:191631141-191631142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs74130249 | chr1:191631152-191631153 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs188507857 | chr1:191631164-191631165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs144228092 | chr1:191631183-191631184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 17086460 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:191630000-191630600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr1:191630200-191630400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr1:191630200-191630600 | Enhancers | H9 Cell Line | embryonic stem cell |
4 | chr1:191630400-191631200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr1:191631200-191631400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr1:191631400-191632200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr1:191632200-191633200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr1:191633200-191634400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr1:191634400-191635800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr1:191635800-191637400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr1:191637800-191638000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
12 | chr1:191638200-191639400 | Enhancers | Muscle Satellite Cultured Cells | -- |
13 | chr1:191638200-191641000 | Enhancers | NH-A | brain |
14 | chr1:191639200-191639400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
15 | chr1:191639400-191640600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
16 | chr1:191639600-191640600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
17 | chr1:191640600-191641000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
18 | chr1:191640600-191641000 | Enhancers | Muscle Satellite Cultured Cells | -- |
19 | chr1:191640600-191641000 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
20 | chr1:191641000-191641200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr1:191641200-191643600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |